Did you know?

Nov 30, 2023 · AbbVie and ImmunoGen said Thursday that the boards of both companies have approved the transaction. It’s expected to close in the middle of 2024. It still needs approval from ImmunoGen shareholders and regulators. Shares of Waltham, Massachusetts.-based ImmunoGen Inc. soared more than 80% to top $29 in mid-morning trading Thursday. May 4, 2023 · Prior to yesterday's news, ImmunoGen stock had been trading at a value of ~$4 - which is about the average across the past 5 year period. Shares ended the day trading at $12.2 - their highest ... AbbVie (ABBV) is set to acquire Immunogen (IMGN) for $10 billion in cash, to access a new cancer drug class called antibody-drug conjugates (ADC). Read more here.ImmunoGen announces FDA accelered approval of Elahere (mirvetuximab soravtansine-gynx) for the treatment of platinum-resistant ovarian cancer. News release. ImmunoGen Inc. November 14, 2022.INVESTOR RELATIONS AND MEDIA CONTACTS ImmunoGen Courtney O'Konek 781-895-0600 [email protected] OR FTI Consulting Robert …ImmunoGen Inc (NASDAQ: IMGN) shares are shooting higher on Wednesday after it announced top-line data from the Phase 3 confirmatory MIRASOL trial (GOG 3045/ENGOT OV-55) evaluating Elahere ...Immunogen's new drug, called Elahere, is the first new treatment option for advanced ovarian cancer to reach the U.S. market in more than seven years.Get the latest ImmunoGen Inc. (IMGN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.AbbVie (ABBV) is set to acquire Immunogen (IMGN) for $10 billion in cash, to access a new cancer drug class called antibody-drug conjugates (ADC). Read more here.Insider Monkey Transcripts. ImmunoGen, Inc. (NASDAQ: IMGN) Q3 2023 Earnings Call Transcript November 2, 2023. ImmunoGen, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were ...Find the latest ImmunoGen, Inc. (IMGN) stock quote, history, news and other vital information to help you with your stock trading and investing. Tweets by goskagit. FILE - This Jan. 24, 2015, file photo, shows the exterior of AbbVie, in Lake Bluff, Ill. AbbVie is buying ImmunoGen in a deal valued at about $10.1 billion with.What's going on at ImmunoGen (NASDAQ:IMGN)? Read today's IMGN news from trusted media outlets at MarketBeat.ImmunoGen reported a net loss of $41.0 million for the quarter. As of March 31, 2023, the company had $201.2 million in cash and cash equivalents, with operational cash usage of $73.7 million.Shares of Waltham, Massachusetts.-based ImmunoGen Inc. soared more than 80% to top $29 in mid-morning trading Thursday. North Chicago, Illinois-based AbbVie Inc. stock was up 2% to $141.26 while ...ImmunoGen names Renee Lentini interim CFO as Susan Altschuller on mediMay. 3, 2023, 06:56 AM. (RTTNews) - ImmunoGen Inc. (IMGN) rep Get the latest ImmunoGen, Inc. (IMGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The need-to-know this morning. • Abbvie s Shares of Waltham, Massachusetts.-based ImmunoGen Inc. soared more than 80% to top $29 in mid-morning trading Thursday. North Chicago, Illinois-based AbbVie Inc. stock was up 2% to $141.26 while ... Updated May 03, 2023, 5:39 pm EDT / Original May 03, 2023,

AbbVie is buying ImmunoGen in a deal valued at about $10.1 billion with the goal of speeding the pharmaceutical's entry into the commercial market for ovarian cancer. ImmunoGen Inc. has the ovarian cancer treatment Elahere. "The acquisition of ImmunoGen demonstrates our commitment to deliver on our long-term growth strategy …The Dow Jones industrials index hit its highest level in 2023 on Thursday, as Salesforce jumped on an upbeat profit forecast and a new report offered further evidence of easing inflation. At 10:37 ET, the Dow Jones Industrial Average DJI was up 0.82% at 35,720.74. The S&P 500 SPX was up 0.07% at 4,553.57 and the Nasdaq Composite …Nov 30, 2023 · Shares of ImmunoGen jumped 82.7 percent to $29.35 on the Nasdaq exchange Thursday. Shares of AbbVie advanced 2.7 percent to $142.34 on the New York Stock Exchange. MEDIA ImmunoGen Courtney O'Konek 781-895-0600 [email protected] OR FTI Consulting Robert Stanislaro 212-850-5657 [email protected]

Dec. 28, 2022, 04:39 PM. (RTTNews) - ImmunoGen, Inc. (IMGN), Wednesday announced Renee Lentini, Vice President of Finance and Chief Accounting Officer, has been appointed interim CFO. The ...Nov 28, 2023 · A high-level overview of ImmunoGen, Inc. (IMGN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. …

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. ImmunoGen drug prolongs survival of women with advanced ov. Possible cause: Nov 30, 2023 · ImmunoGen’s stock soared 81% in morning trading, putting it on tra.